• Apicidin as a Histone Deacetylase Inhibitor: Workflows & Ins

  2026-05-25

  Apicidin is a potent, selective histone deacetylase inhibitor that enables advanced modeling of epigenetic regulation, cancer cell proliferation, and reproductive toxicity. This guide distills applied protocols, experimental troubleshooting, and novel findings, helping researchers leverage Apicidin for high-impact bench research.

• Enhancing Immunofluorescence: FITC Goat Anti-Rabbit IgG (H+L

  2026-05-25

  Explore how the FITC Goat Anti-Rabbit IgG (H+L) Antibody elevates immunofluorescence sensitivity in barrier integrity and inflammation studies. This article uniquely bridges robust signal amplification with practical insights from recent inflammasome research, offering workflow guidance for demanding biological assays.

• TaqI Restriction Endonuclease: Rapid, Sequence-Specific DNA

  2026-05-24

  TaqI Restriction Endonuclease (SKU K3053) offers a fast and reliable solution for molecular biologists requiring efficient and sequence-specific cleavage of plasmid, PCR, or genomic DNA. Its rapid digestion protocol and sticky end generation streamline DNA cloning and analysis workflows. This enzyme is not intended for diagnostic or medical use and should be employed strictly in research settings.

• Angiotensin III (human, mouse): Advanced RAAS Peptide Insigh

  2026-05-23

  Explore Angiotensin III (human, mouse) as a unique cardiovascular research peptide, with deep analysis on its mechanistic role in RAAS, receptor specificity, and cross-domain relevance—offering insights and practical protocols beyond existing sources.

• Ibuprofen in Colon Cancer: Mechanistic Insights for Translat

  2026-05-22

  This thought-leadership article explores the dual COX-1/COX-2 inhibition of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid), its anti-proliferative effects in colon carcinoma models, and strategic guidance for translational researchers. Integrating mechanistic data and hands-on protocol parameters, the article bridges foundational oncology research with real-world assay optimization, contextualizing APExBIO's Ibuprofen product within the competitive landscape.

• Angiotensin III (human, mouse): Mechanistic Insights and Tra

  2026-05-22

  Explore the mechanistic roles and translational assay implications of Angiotensin III (human, mouse) in RAAS research. This article uniquely analyzes structure-function insights and practical workflow decisions, advancing the field beyond standard peptide characterization.

• Cy3 Goat Anti-Rabbit IgG (H+L): Unlocking Early DN Biomarker

  2026-05-21

  This thought-leadership article explores how Cy3 Goat Anti-Rabbit IgG (H+L) Antibody accelerates the detection of early diabetic nephropathy biomarkers through advanced immunofluorescence, integrating mechanistic insight with translational strategy. We bridge recent proteomics breakthroughs, competitive antibody technologies, and workflow protocols to guide researchers in maximizing signal sensitivity and experimental reproducibility. Drawing on landmark HMGB1 research and APExBIO’s product innovations, we chart a path toward next-generation diagnostics.

• 5-Azacytidine-Induced Dormancy Suppresses Metastatic Outgrow

  2026-05-21

  Singh et al. (2023) demonstrate that the DNA demethylation agent 5-Azacytidine, combined with retinoic acid, reprograms disseminated cancer cells (DCCs) into a dormant state via restored TGF-β-SMAD4 signaling, effectively suppressing metastasis. This mechanistic insight provides a compelling epigenetic strategy for metastasis prevention and highlights the significance of targeting chromatin states to control cancer progression.

• Scalable Production of EPSC-iMSC Extracellular Vesicles for

  2026-05-20

  Gong et al. introduce a robust bioreactor-based platform to generate extracellular vesicles (EVs) from induced mesenchymal stem cells (iMSCs) derived from extended pluripotent stem cells (EPSCs). Their approach addresses key limitations in EV manufacturing, delivering consistent, high-yield, clinically relevant EVs with therapeutic efficacy demonstrated in a mouse pulmonary fibrosis model.

• P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via PI3K/Akt

  2026-05-20

  This study reveals that P2RX1 overexpression sensitizes Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cells to mitochondrial apoptosis by disrupting calcium homeostasis and suppressing PI3K/Akt signaling. The mechanistic insights highlight P2RX1 as a potential therapeutic target and inform new strategies for overcoming tyrosine kinase inhibitor resistance in Ph+ ALL.

• Mannosylated LNPs Enhance In Vivo Targeted mRNA Delivery

  2026-05-19

  The reference study introduces cholesterol-derived mannosylated polypeptides for lipid nanoparticle (LNP) formulation, enabling targeted and efficient in vivo mRNA delivery to antigen-presenting cells (APCs). This approach significantly improves lymph node targeting and mRNA expression over conventional LNPs, offering implications for next-generation mRNA vaccine design.

• SP2509: Next-Generation Lysine-Specific Demethylase 1 Antago

  2026-05-19

  SP2509 is a powerful, nanomolar-potency Lysine-specific demethylase 1 antagonist with unmatched selectivity for epigenetic cancer research. Its robust induction of apoptosis and differentiation in AML models makes it indispensable for dissecting cancer epigenetics and optimizing experimental workflows.

• Vancomycin Hydrochloride in PK/PD-Driven Antibiotic Resistan

  2026-05-18

  Discover how Vancomycin hydrochloride empowers advanced glycopeptide antibacterial agent research and antibiotic resistance assays. This article uniquely bridges semi-mechanistic pharmacodynamic modeling, experimental protocol optimization, and translational insights for Gram-positive bacterial inhibition.

• cgSHAPE-seq Maps RNA-Degrading Chimera Sites in SARS-CoV-2 5

  2026-05-18

  This study introduces cgSHAPE-seq, a sequencing-based method to pinpoint small-molecule binding sites on structured RNA, and applies it to optimize RNA-degrading chimeras targeting the highly conserved SL5 element in the SARS-CoV-2 5’ UTR. The findings advance strategies for mechanistic mapping and rational design of RNA-targeted antivirals, with implications for both basic research and therapeutic development.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-05-17

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to its cellular receptors, especially AXL. These findings suggest a previously unrecognized molecular link between the renin-angiotensin-aldosterone system and COVID-19 pathogenesis, and highlight new directions for mechanistic and therapeutic research.

10211 records 2/681 page Previous Next 12345 下5页 Last page